Theralase Technologies Inc. V.TLT

Alternate Symbol(s): V.TLT.W | TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc. > 2 things

<< Previous

Bullboard Posts

Next >>

Comment by thadeushon Jan 29, 2024 12:43pm

226 Views

Post# 35850727

RE:RE:RE:RE:RE:RE:2 things

I'd be very surprised if Merck or any big drug company was NOT aware of TLT. That doesn't necessarily make TLT unique - I'm sure every drug/process that makes it to Phase 2 must be watched very carefully by big pharma for potential acquisition. The average investor may not be aware of Theralase, but there's probably a whole department evaluating promising new companies to see who gets the next billion dollar boost

<< Previous

Bullboard Posts

Next >>

Red Light Holland and Costco Canada partner on mushroom kits